|
|
|
|
|
|
|
|
 |
|
|
| |
Si Usted es Socio de la SLIPE y se ha publicado un artículo en el que participa en los últimos 5 años, es decir a partir de Abril 2005, por favor hágalo llegar a esta dirección electrónica: info@slipe.org |
| |
|
| |
|
| |
|
 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Long-term Safety and Efficacy Results of Once-Daily Emtricitabine-Based Highly Active Antiretroviral Therapy Regimens in Human Immunodeficiency Virus-Infected Pediatric Subjects |
 |
|
| |
Xavier Saez-Llorens, Avy Violari, Dalubuhle Ndiweni, Ram Yogev, Miguel Cashat, Andrew Wiznia, Greg Chittick, Jeanette Harris, John Hinkle, M. Robert Blum, Nathalie Adda, Franck Rousseau and for the FTC-203 Study Team.
Pediatrics 2008;121;e827-e835. |
| |
|
|
|
|
|
|
| |
An International serotype 3 clone causing pediatric noninvasive infections in Israel, Costa Rica, and Lithuania |
|
|
| |
Nurith Porat, PhD, Carolina Soley, MD, Marija M. Marengolciene, MD, David Greenberg, MD, Noga Givon-Lavi, PhD, Ronit Trefler, BS, Adriano Arguedas, MD, and Ron Dagan, MD.
The Pediatric Infectious Disease Journal. 2008 Aug., 27 (8): 709–12. |
| |
|
|
|
|
|
|
|
|
| |
Seasonal distribution of Otitis Media Pathogens among Costa Rican children |
|
|
| |
Silvia Guevara, MD, Carolina Soley, MD, Adriano Arguedas, MD, Nurith Porat, PhD, and Ron Dagan, MD.
The Pediatric Infectious Disease Journal , 2008 Jan., 27,( 1): 12–6. |
| |
|
|
|
|
| |
Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial |
|
|
| |
Santolaya ME, Alvarez AM, Aviles CL, Becker A, King A, Mosso C, O´Ryan M, Paya E, Salgado C, Silva P, Topelberg S, Tordecilla J, Varas M, Villarroel M, Viviani T, Zubieta M.
Pediatr Infect Dis J. 2008 Jun;27(6):538-43. |
| |
|
|
|
|
|
|
|
|
|
|
| |
Influence of admission findings on death and neurological outcome from childhood bacterial meningitis |
|
|
| |
Roine I, Peltola H, Fernández J, Zavala I, González Mata A, González Ayala S, Arbo A, Bologna R, Miño G, Goyo J, López E, Dourado de Andrade S, Sarna S.
Clin Infect Dis. 2008 Apr 15;46(8):1248-52. |
| |
|
|
|
|
| |
Resultados a largo plazo de seguridad y la eficacia de los regímenes de terapia antirretroviral altamente activa basada en emtricitabina de una vez al día en temas pediátricos infectados por el virus de inmunodeficiencia humana |
|
|
| |
- Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects -
Saez-Llorens X, Violari A, Ndiweni D, Yogev R, Cashat M, Wiznia A, Chittick G, Harris J, Hinkle J, Blum MR, Adda N, Rousseau F; FTC-203 Study Team.
Pediatrics. 2008 Apr;121(4):e827-35. |
| |
|
|
|
|
| |
Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study |
|
|
| |
Linhares AC, Velázquez FR, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F, López P, Macías-Parra M, Ortega-Barría E, Rivera-Medina DM, Rivera L, Pavía-Ruz N, Nuñez E, Damaso S, Ruiz-Palacios GM, De Vos B, O´Ryan M, Gillard P, Bouckenooghe A; Human Rotavirus Vaccine Study Group.
Lancet. 2008 Apr 5;371(9619):1181-9. |
| |
|
|
|
|
|
|
| |
Micafungin Versus Liposomal Amphotericin B for Pediatric Patients With Invasive Candidiasis Substudy of a Randomized Double-Blind Trial |
|
|
| |
Flavio Queiroz-Telles, MD, Eitan Berezin, MD, Guy Leverger, MD, Antonio Freire, MD, Annalie van der Vyver, MD, Tawee Chotpitayasunondh, MD, Josip Konja, MD, Heike Diekmann-Berndt, PhD, Sonja Koblinger, MD, Andreas H. Groll, MD, and Antonio Arrieta, MD, for the Micafungin Invasive Candidiasis Study Group.
Pediatr Infect Dis J 2008;27: 820–826. |
| |
|
|
|
|
| |
Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study) |
|
|
| |
Asghar R, Banajeh S, Egas J, Hibberd P, Iqbal I, Katep-Bwalya M, Kundi Z, Law P, MacLeod W, Maulen-Radovan I, Miño G, Saha S, Sempertegui F, Simon J, Santosham M, Singhi S, Thea DM, Qazi S; Severe Pneumonia Evaluation Antimicrobial Research Study Group.
BMJ. 2008 Jan 12;336(7635):80-4
|
| |
|
|
|
|
|
|
|
|
|
|
|
